Beam Therapeutics Layoffs 2024. They join a list of more than 130 biotechs that have laid off employees this year as the sector struggles with a shaky stock market. Smaller firms continue to bear the brunt of funding woes.
Listen to this article 3 min. Beam therapeutics cell & gene therapy base editing.
Smaller Firms Continue To Bear The Brunt Of Funding Woes.
Beam therapeutics ( nasdaq:beam) is a gene editing company โ one that gets less attention than its peers.
By Max Bayer Oct 19, 2023 11:00Am.
Gene editing company beam therapeutics became the latest biotech to announce staff layoffs oct.
They Join A List Of More Than 130 Biotechs That Have Laid Off Employees This Year As The Sector Struggles With A Shaky Stock Market.
Images References :
Beam), A Biotechnology Company Developing Precision Genetic Medicines.
Beam therapeutics, a cambridge biotech developing medicines that rely on gene editing, said thursday that it will lay off about 100 employees, 20 percent of its.
B Eam Therapeutics Said Thursday Morning It Would Lay Off 20% Of Its Staff โ Or Around 100 Employees โ And Pause Or Reevaluate Certain Programs As It Looks To.
Conditions may be more difficult for such a spark to take hold in 2024 after a year in which more than 120 public biotech companies laid off staff.
Beam Therapeutics Cell &Amp; Gene Therapy Base Editing.